117 related articles for article (PubMed ID: 2118928)
1. Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?
Marcellin P; Giostra E; Boyer N; Loriot MA; Martinot-Peignoux M; Benhamou JP
J Hepatol; 1990 Jul; 11(1):77-9. PubMed ID: 2118928
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C.
Lampertico P; Rumi M; Romeo R; Craxì A; Soffredini R; Biassoni D; Colombo M
Hepatology; 1994 Jan; 19(1):19-22. PubMed ID: 7506225
[TBL] [Abstract][Full Text] [Related]
4. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
Marcellin P; Boyer N; Giostra E; Degott C; Courouce AM; Degos F; Coppere H; Cales P; Couzigou P; Benhamou JP
Hepatology; 1991 Mar; 13(3):393-7. PubMed ID: 1900254
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
7. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis virus C: from discovery to applications in public health].
Trépo C
Rev Prat; 1990 Jun; 40(18):1631-9. PubMed ID: 2115200
[TBL] [Abstract][Full Text] [Related]
9. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
[TBL] [Abstract][Full Text] [Related]
10. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
Ohnishi K; Nomura F; Nakano M
Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.
Schvarcz R; Weiland O; Wejstål R; Norkrans G; Frydén A; Foberg U
Scand J Infect Dis; 1989; 21(6):617-25. PubMed ID: 2482536
[TBL] [Abstract][Full Text] [Related]
16. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
Ruiz-Moreno M; Rua MJ; Castillo I; García-Novo MD; Santos M; Navas S; Carreño V
Hepatology; 1992 Oct; 16(4):882-5. PubMed ID: 1328009
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
[TBL] [Abstract][Full Text] [Related]
20. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]